| Date | Time | Source | Headline | Symbol | Company |
| 02/16/2007 | 8:30AM | PR Newswire (US) | GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 02/16/2007 | 8:30AM | PR Newswire (US) | GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 02/15/2007 | 9:00AM | PR Newswire (US) | GlaxoSmithKline Extends Subsequent Offering Period By One Day | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 02/07/2007 | 9:11AM | PR Newswire (US) | GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 01/09/2007 | 9:03AM | PR Newswire (US) | GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/09/2006 | 7:15AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/08/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/01/2006 | 2:02PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 10/24/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 10/18/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 08/04/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 08/01/2006 | 4:30PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 06/20/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 05/05/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 04/28/2006 | 7:30AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 04/20/2006 | 8:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Appoints Prem Das as Senior Vice President, Technology Partnerships | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 04/10/2006 | 7:30AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Pilot Study and Option Agreement with GlaxoSmithKline to Utilize DirectSelect(TM | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 03/21/2006 | 7:30AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Technology Transfer and Option Agreement with Gilead Sciences, Inc. to Utilize D | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 03/15/2006 | 8:30AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 03/09/2006 | 2:00PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 in Rheumatoid Arthritis | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 02/22/2006 | 8:30AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 02/09/2006 | 4:51PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 02/03/2006 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Fourth Quarter and Year End 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 01/30/2006 | 2:40PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Fourth Quarter and Year End 2005 Financial Results on Friday, February 3, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/07/2005 | 6:15PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 9, | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/04/2005 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/01/2005 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter 2005 Financial Results on Friday, November 4, 2005 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 10/27/2005 | 4:17PM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Stockholders Authorize Reverse Stock Split; Board Sets 1-for-5 Split Ratio | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 10/19/2005 | 7:00AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Completes Sale of Facility for $51.25 Million | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 10/11/2005 | 9:12AM | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Agreement for Sale of Facility | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |